ENUMERAL BIOMEDICAL
Enumeral Biomedical uses its microengraving (nanotechnology-enabled) process to address opportunities in immunology including therapeutic discovery, immune profiling and personalized medicine.
ENUMERAL BIOMEDICAL
Industry:
Biotechnology Nanotechnology Therapeutics
Founded:
2009-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.enumeral.com
Total Employee:
11+
Status:
Closed
Contact:
2127523633
Email Addresses:
[email protected]
Total Funding:
32.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Organization Schema IPv6 Google Apps For Business Cloudflare
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is OTCQB:ENUM
Investors List
180 Degree Capital
180 Degree Capital investment in Post-IPO Equity - Enumeral Biomedical
Montrose Capital Partners
Montrose Capital Partners investment in Post-IPO Equity - Enumeral Biomedical
Bantam Group
Bantam Group investment in Seed Round - Enumeral Biomedical
Official Site Inspections
http://www.enumeral.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
Loading ... 